CAS# | 16789-98-3 |
氨基酸序列 | [Mpr-Tyr-Phe-Gln-Asn-Cys]-Pro-D-Arg-Gly-NH2 |
证书 | NMPA |
登记号 | Y20170000345 |
DMF | Available |
Quality Standard | EP,USP,CP |
生产(chǎn)规模 | Kgs |
库存 | Available |
包装(zhuāng) | 10g /bottle 30g /bottle |
HS CODE | 2937190099 |
用(yòng)途 | 中(zhōng)枢性尿崩症及颅外伤或手术所致的暂时性尿崩症:用(yòng)后可(kě)减少尿排出,增加尿渗透压,减低血浆渗透压,减少尿频和夜尿(一般对肾源性尿崩症无效)。治疗5岁以上患有(yǒu)夜间遗尿症的患者。肾尿液浓缩功能(néng)试验:有(yǒu)助于对肾功能(néng)的鉴别,对于诊断不同部位的尿道感染尤其有(yǒu)效。对于轻度血友病及Ⅰ型血管性血友病患者,在进行小(xiǎo)型外科(kē)手术时可(kě)控制出血或预防出血。对于因尿毒症、肝硬化以及先天的或用(yòng)药诱发的血小(xiǎo)板功能(néng)障碍而引起的出血时间过長(cháng)和不明原因的出血,用(yòng)本品可(kě)使出血时间缩短或恢复正常。 Oral formulations may be used to manage primary nocturnal enuresis in adults and vasopressin sensitive diabetes insipidus, and for control of temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. Intranasal and parenteral formulations may be used to manage spontaneous or trauma-induced bleeds (e.g. hemarthrosis, intramuscular hematoma, mucosal bleeding) in patients with hemophilia A or von Willebrand’s disease Type I. May also be used parenterally to prevent or treat bleeding in patients with uremia. |